Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.

Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.

The distribution of bone morphogenetic protein (BMP) type I receptors and the activin type I receptor (ActR-I) was investigated in 16 cases of human glioma and five cases of non-tumourous gliosis tissue by immunohistochemical technique. Both BMP type IA (BMPR-IA) and the type IB (BMPR-IB) receptors...

Full description

Bibliographic Details
Main Authors: Yamada, N., Kato, M., ten Dijke, P., Yamashita, H., Sampath, T. K., Heldin, C. H., Miyazono, K., Funa, K.
Format: Online
Language:English
Published: Nature Publishing Group 1996
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074358/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074358/

Similar Items